C6A-15448-03339 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-08
Registered in v-safe
2021-03-11
Dose 1 — Moderna
2021-03-11
Survey response — day 0, dose 1
MedDRA: Dysgeusia — Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness, Nausea · Be unable to work

Free text: Metallic taste

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-11
Report sent to call center — day 0, dose 1
Be unable to work

1 call case(s)
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2021-03-12
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-11	Moderna

Call center

2 call center cases

2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 5 — day 0, dose 1

2021-03-11

Systemic reaction (other): Metallic taste

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dysgeusia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release